BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS • Currently down 0.26 (-2.97%) in today's trading session

Track congressional stock trades in BioCryst Pharmaceuticals, Inc. (BCRX). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

BioCryst Pharmaceuticals, Inc. is currently trading at $8.49, positioned at 47% of its 52-week range ($6.00 – $11.31). View which politicians have recently bought or sold BCRX and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio in real-time with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$8.49
24h Change
-0.26 (-2.97%)
52 Week Range
$6.00—$11.31
View on NASDAQ

BioCryst Pharmaceuticals, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BCRX

Select to highlight on chart
1 transactions
Compliance: 100%
Josh Gottheimer11 Aug 202216 Sept 2022PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.78B

Volume

2.97M

Beta

0.76

P/E Ratio

7.02

Fundamentals

EPS

$1.21

Div. Yield

—

Open

$8.69

Day Range

$8.39 — $8.79

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Charles K. Gayer
IPO Date
1994-03-04
Website
www.biocryst.com

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the...

Earnings

Next Report

Q1 2026

4 May

EPS Est.

$0.05

Rev. Est.

$151.7M

Days Until

53

Recent Quarters

Q4 202526 Feb
EPS$1.12
Beat 2219.8%
Q3 20253 Nov
EPS$0.06
Miss 14.3%
Q2 20254 Aug
EPS$0.15
Beat 400.0%
Q1 20255 May
EPS$0.00
Beat 100.2%
Q4 202424 Feb
EPS$-0.13
Miss 85.7%
Q3 20244 Nov
EPS$-0.07
Beat 0.0%
Q2 20245 Aug
EPS$-0.06
Beat 68.4%
Q1 20246 May
EPS$-0.17
Beat 26.1%
Q4 202326 Feb
EPS$-0.28
Miss 16.7%
Q3 20232 Nov
EPS$-0.19
Beat 24.0%
Q2 20233 Aug
EPS$-0.24
Beat 4.0%
Q1 20233 May
EPS$-0.28
Beat 6.7%
Q4 202221 Feb
EPS$-0.38
Miss 100.0%
Q3 20221 Nov
EPS$-0.23
Beat 28.1%
Q2 20224 Aug
EPS$-0.32
Beat 11.1%
Q1 20225 May
EPS$-0.40
Miss 2.6%
Q4 202123 Feb
EPS$-0.40
Miss 29.0%
Q3 20213 Nov
EPS$-0.33
Miss 10.0%
Q2 20215 Aug
EPS$-0.24
Miss 9.1%
Q1 20216 May
EPS$-0.36
Miss 38.5%
Q4 202025 Feb
EPS$-0.34
Miss 36.0%
Q3 20205 Nov
EPS$-0.26
Miss 4.0%
Q2 20206 Aug
EPS$-0.24
Beat 14.3%
Q1 20206 May
EPS$-0.24
Beat 7.7%
Q4 20195 Mar
EPS$-0.02
Beat 92.0%
Q3 20196 Nov
EPS$-0.34
Miss 9.7%
Q2 20196 Aug
EPS$-0.34
Miss 9.7%
Q1 20198 May
EPS$-0.28
Beat 0.0%
Q4 20184 Mar
EPS$-0.25
Beat 3.9%
Q3 20186 Nov
EPS$-0.28
Miss 12.0%
Q2 20187 Aug
EPS$-0.19
Beat 17.4%
Q1 20188 May
EPS$-0.26
Miss 62.5%
Q4 201727 Feb
EPS$-0.20
Miss 42.9%
Q3 20177 Nov
EPS$-0.18
Miss 5.9%
Q2 20177 Aug
EPS$-0.21
Miss 10.5%
Q1 20174 May
EPS$-0.19
Beat 5.0%
Q4 201627 Feb
EPS$-0.06
Beat 76.0%
Q3 20167 Nov
EPS$-0.16
Beat 30.4%
Q2 20164 Aug
EPS$-0.22
Beat 8.3%
Q1 20165 May
EPS$-0.31
Miss 34.8%
Q4 201523 Feb
EPS$-0.25
Beat 0.0%
Q3 20155 Nov
EPS$-0.20
Beat 0.0%
Q2 20157 Aug
EPS$0.06
Beat 127.3%
Q1 20158 May
EPS$-0.21
Beat 12.5%
Q4 201418 Feb
EPS$-0.16
Beat 20.0%
Q3 20146 Nov
EPS$-0.12
Beat 36.8%
Q2 20145 Aug
EPS$-0.23
Miss 21.1%
Q1 20148 May
EPS$-0.17
Miss 6.3%
Q4 201326 Feb
EPS$-0.09
Beat 18.2%
Q3 20135 Nov
EPS$-0.14
Miss 7.7%
Q2 20138 Aug
EPS$-0.23
Miss 91.7%
Q1 20137 May
EPS$-0.09
Beat 25.0%
Q4 201219 Feb
EPS$-0.20
Beat 20.0%
Q3 20128 Nov
EPS$-0.19
Beat 24.0%
Q2 20122 Aug
EPS$-0.25
Beat 3.9%
Q1 20127 May
EPS$-0.13
Beat 50.0%
Q4 201116 Feb
EPS$-0.29
Miss 3.6%
Q3 20112 Nov
EPS$-0.32
Miss 23.1%
Q2 20114 Aug
EPS$-0.36
Miss 44.0%
Q1 20114 May
EPS$-0.29
Miss 45.0%
Q4 201010 Feb
EPS$-0.20
Beat 4.8%
Q3 201028 Oct
EPS$-0.24
Miss 41.2%
Q2 20105 Aug
EPS$-0.23
Miss 4.5%
Q1 201028 Apr
EPS$-0.06
Beat 62.5%
Q4 20094 Feb
EPS$0.35
Beat 288.9%
Q3 200929 Oct
EPS$-0.28
Miss 27.3%
Q2 200930 Jul
EPS$-0.23
Beat 8.0%
Q1 20098 May
EPS$-0.24
Beat 14.3%
Q4 20086 Feb
EPS$0.26
Beat 218.2%
Q3 200831 Oct
EPS$-0.24
Beat 0.0%
Q2 20087 Aug
EPS$-0.33
Miss 65.0%
Q1 20088 May
EPS$-0.34
Miss 88.9%
Q4 20074 Mar
EPS$-0.06
Beat 84.6%
Q3 20078 Nov
EPS$-0.32
Miss 14.3%
Q2 20079 Aug
EPS$-0.24
Beat 27.3%
Q1 20079 May
EPS$-0.30
Miss 11.1%
Q4 20067 Feb
EPS$-0.34
Beat 32.0%
Q3 20068 Nov
EPS$-0.53
Miss 29.3%
Q2 20069 Aug
EPS$-0.35
Miss 20.7%
Q1 200627 Apr
EPS$-0.27
Miss 12.5%
Q4 20058 Feb
EPS$-0.27
Beat 6.9%
Q3 200526 Oct
EPS$-0.29
Miss 20.8%
Q2 20053 Aug
EPS$-0.22
Beat 12.0%
Q1 200521 Apr
EPS$-0.24
Beat 0.0%
Q4 20042 Feb
EPS$-0.24
Beat 7.7%
Q3 200420 Oct
EPS$-0.24
Beat 0.0%
Q2 200421 Jul
EPS$-0.23
Beat 17.9%
Q1 200421 Apr
EPS$-0.28
Miss 27.3%
Q4 200319 Mar
EPS$-0.17
Q4 20034 Feb
EPS$-0.18
Beat 10.0%
Q2 200313 Aug
EPS$-0.18
Q1 20039 May
EPS$-0.16
Q4 200221 Mar
EPS$-0.15
Q3 200212 Nov
EPS$-0.19
Q2 20027 Aug
EPS$-0.29
Q1 20023 May
EPS$-0.32
Q4 200130 Jan
EPS$-0.28
Miss 100.0%
Q3 200124 Oct
EPS$0.02
Beat 115.4%
Q2 200125 Jul
EPS$-0.08
Beat 33.3%
Q1 200125 Apr
EPS$-0.08
Beat 27.3%
Q4 20001 Feb
EPS$-0.11
Beat 8.3%
Q3 200025 Oct
EPS$-0.09
Beat 18.2%
Q2 200026 Jul
EPS$-0.11
Beat 8.3%
Q1 200026 Apr
EPS$0.10
Beat 385.7%
Q4 19992 Feb
EPS$-0.03
Miss 125.1%
Q3 199921 Oct
EPS$-0.15
Beat 16.7%
Q2 199913 Aug
EPS$-0.02
Q2 199921 Jul
EPS$-0.02
Beat 75.0%
Q4 199827 Jan
EPS$-0.10
Beat 58.3%
Q3 199828 Oct
EPS$0.19
Beat 5.6%
Q2 199814 Aug
EPS$-0.21
Q2 199822 Jul
EPS$-0.21
Beat 16.0%
Q4 199724 Mar
EPS$-0.21
Q4 19973 Feb
EPS$-0.21
Beat 8.7%
Q2 19975 Aug
EPS$-0.15
Q1 199728 Apr
EPS$-0.23
Miss 91.7%
Q4 199610 Feb
EPS$-0.15
Beat 28.6%
Q3 199629 Oct
EPS$-0.23
Beat 17.9%
Q2 199625 Jul
EPS$-0.11
Miss 320.0%
Q1 199624 Apr
EPS$-0.20
Beat 23.1%
Q4 199529 Jan
EPS$-0.23
Beat 11.5%
Q3 199517 Oct
EPS$-0.20
Beat 13.0%
Q2 199525 Jul
EPS$-0.18
Beat 45.5%
Q1 199528 Apr
EPS$-0.37
Miss 19.4%
Q4 199431 Jan
EPS$-0.24
Beat 7.7%
Q3 199426 Oct
EPS$-0.22
Beat 29.0%
Q2 19942 Aug
EPS$-0.25
Beat 24.2%
Q1 199430 Jun
EPS$-0.25

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

LLY

Eli Lilly and Company

47
$999.84-1.51 (-0.15%)
Healthcare
Held by same politician
Same sector: Healthcare
1 politician
View Stock

NVDA

NVIDIA Corporation

20
$186.03+1.26 (+0.68%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock
Pelosi TrackerJoin our Discord
PoliticiansPortfoliosPricingLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.